U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Northern Trust Corp

Northern Trust Corp boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 13.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 261,825 shares of the company's stock after acquiring an additional 32,024 shares during the period. Northern Trust Corp owned about 1.73% of U.S. Physical Therapy worth $23,226,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in USPH. Harbor Capital Advisors Inc. lifted its position in shares of U.S. Physical Therapy by 1.0% during the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company's stock worth $1,450,000 after buying an additional 156 shares during the last quarter. Park Avenue Securities LLC lifted its position in shares of U.S. Physical Therapy by 58.1% during the 4th quarter. Park Avenue Securities LLC now owns 4,694 shares of the company's stock worth $416,000 after buying an additional 1,725 shares during the last quarter. Legacy Wealth Asset Management LLC lifted its position in shares of U.S. Physical Therapy by 11.1% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 9,510 shares of the company's stock worth $844,000 after buying an additional 953 shares during the last quarter. Albert D Mason Inc. lifted its position in shares of U.S. Physical Therapy by 1.3% during the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company's stock worth $940,000 after buying an additional 139 shares during the last quarter. Finally, Sugar Maple Asset Management LLC lifted its position in shares of U.S. Physical Therapy by 60.0% during the 4th quarter. Sugar Maple Asset Management LLC now owns 4,000 shares of the company's stock worth $355,000 after buying an additional 1,500 shares during the last quarter.

U.S. Physical Therapy Stock Performance

USPH traded up $1.63 during trading on Friday, hitting $79.90. The stock had a trading volume of 117,216 shares, compared to its average volume of 110,831. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a market capitalization of $1.21 billion, a P/E ratio of 84.99, a PEG ratio of 3.54 and a beta of 1.44. The company's 50-day moving average price is $71.85 and its 200 day moving average price is $83.57. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $107.09.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.51 EPS. On average, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.25%. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. This represents a 19.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.00% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

USPH has been the subject of several research reports. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.